A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial

BACKGROUND: Malignant pleural mesothelioma is an incurable cancer caused by exposure to asbestos. The United Kingdom has the highest death rate from mesothelioma in the world and this figure is increasing. Median survival is 8 to 12 months, and most patients have symptoms at diagnosis. The fittest p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunatilake, Samal, Brims, Fraser JH, Fogg, Carole, Lawrie, Iain, Maskell, Nick, Forbes, Karen, Rahman, Najib, Morris, Steve, Ogollah, Reuben, Gerry, Stephen, Peake, Mick, Darlison, Liz, Chauhan, Anoop J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180732/
https://www.ncbi.nlm.nih.gov/pubmed/25238873
http://dx.doi.org/10.1186/1745-6215-15-367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180732/
https://www.ncbi.nlm.nih.gov/pubmed/25238873
http://dx.doi.org/10.1186/1745-6215-15-367

Ejemplares similares